撤稿声明：“布南色林对初发未使用抗精神病药物的精神分裂症患者认知功能的影响”

Retraction: 'Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia'.

作者信息

Tenjin Tomomi, Miyamoto Seiya, Miyake Nobumi, Ogino Shin, Kitajima Rei, Ojima Kazuaki, Arai Jun, Teramoto Haruki, Tsukahara Sachiko, Ito Yukie, Tadokoro Masanori, Anai Kiriko, Funamoto Yasuyuki, Kaneda Yasuhiro, Sumiyoshi Tomiki, Yamaguchi Noboru

出版信息

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2622. Epub 2017 Jun 1.

DOI:10.1002/hup.2622

PMID:28657182

Abstract

UNLABELLED

The above article from Human Psychopharmacology, first published on 25 January 2012 in Wiley OnlineLibrary (onlinelibrary.wiley.com), and in Volume 90, pp. 90-100, has been retracted by agreement between the authors, the journal Editor in Chief, David Baldwin, and John Wiley & Sons Ltd. The retraction has been agreed following an investigation by the St Marianna University Ethics Committee which determined that the paper was not as originally designed and approved.

REFERENCES

Tenjin, T., Miyamoto, S., Miyake, N., Ogino, S., Kitajima, R., Ojima, K., … Yamaguchi, N. (2012). Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia. Hum. Psychopharmacol Clin Exp, 27, 90-100. https://doi.org/10.1002/hup.1276.

摘要

未标注

上述发表于《人类精神药理学》的文章，于2012年1月25日首次发表在Wiley OnlineLibrary（onlinelibrary.wiley.com）上，载于第90卷，第90 - 100页，经作者、期刊主编大卫·鲍德温以及约翰·威利父子有限公司协商一致后予以撤回。此次撤回是在圣玛丽安娜大学伦理委员会进行调查后达成的，该委员会认定该论文并非最初设计并获批的那样。